stella
beta
A Multicenter, Phase 3, Randomized Trial of Sequencial Chemoradiotherapy with or Without Toripalimab (PD-1 Antibody) in Newly Diagnosed Early-Stage Extranodal Natural Killer/T Cell Lymphoma, Nasal Type (ENKTL) — Stella
Recruiting
Back to NK/T Cell Lymphoma Nos trials
Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.
Trial locations
(1 site)
China
Guangdong General Hospital, Guangzhou, Guangdong
View full record on ClinicalTrials.gov